Saturday February 22, 2020

Reaching the holy grail of precision medicine

Irish company Diaceutics is at the centre of a high-tech revolution in personalised medicine that promises fast and more effective treatments

23rd April, 2017
Peter Keeling, chief executive, Diaceutics

Pharmaceuticals is not an industry that moves forward in straight lines. Massive leaps in the lab have in the past been followed by blockbuster drugs, as well as by long periods of unfulfilled promise.

Precision medicine – the dream of medicine tailored to the specific, individual needs of patients and groups of patients – has long promised not only the next great leap forward, but also an end to the dry spells. That era may...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team